Our Focus

Late stage compounds which enrich regional value 

Japan: Oncology, Specialty Medicine
US: Oncology
EU: Synergistic effect on Lixiana

Japan

Late stage or marketed oncology and specialty medicine products

• In CVM (w/ LIXIANA®, EFIENT®, Minnebro, TENELIA®, and Canaglu)
• CNS (w/ Memary® and Vimpat®)
• Orthopedic (w/ PRALIA® and TARLIGE®)
• GI (w/ Nexium®)
• Oncology (w/ VANFLYTA and ENHERTU®)

US

Late stage or marketed oncology products

• Late stage or marketed products in Oncology (w/ENHERTU®)

EU

Late stage or marketed products with a synergistic effect on LIXIANA® 

•  In CVM (w/ LIXIANA® and Nilemdo/Nustendi) or Oncology (w/ ENHERTU®)     

 

Submit a non-confidential proposal